The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype

The fibroblast growth factor 21 (FGF21) is a new biomarker of mitochondrial diseases (MD). FGF21 concentration may be used to define the severity of mitochondrial disease. AIM OF THE STUDY: The study objective was to verify if the FGF21 concentration in paediatric patients with MD was correlated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Wesół-Kucharska, Dorota, Rokicki, Dariusz, Greczan, Milena, Kaczor, Magdalena, Czkuć-Kryśkiewicz, Edyta, Piekutowska-Abramczuk, Dorota, Halat-Wolska, Paulina, Ciara, Elżbieta, Jaworski, Maciej, Jezela-Stanek, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original paper | Praca oryginalna
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214940/
https://www.ncbi.nlm.nih.gov/pubmed/35620925
http://dx.doi.org/10.5114/pedm.2022.116116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214940/
https://www.ncbi.nlm.nih.gov/pubmed/35620925
http://dx.doi.org/10.5114/pedm.2022.116116

Ejemplares similares